Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells

Peili Wu, Pei-Li Wu, Cheng Zeng, Yingfang Zhou, Ying-Fang Zhou, Ling Yin, Xiao-Lan Yu, Xiaolan Yu, Qing Xue
Reproductive sciences (Thousand Oaks, Calif.) · 2018 · vol. 26(8) , pp. 1111–1120 · doi:10.1177/1933719118808912 · PMID:30428773 · W2901898290
article OA: closed CC0 ⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

The farnesoid X receptor agonist GW4064 was found to inhibit aromatase and ERβ expression in human endometriotic stromal cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Aromatase Endometrium Estrogen Receptor beta Isoxazoles Receptors, Cytoplasmic and Nuclear Stromal Cells Adenylate Kinase Adenylate Kinase Animals Aromatase Cyclic AMP Response Element-Binding Protein Cyclic AMP Response Element-Binding Protein Endometrium Endometrium Estrogen Receptor beta Female Humans Isoxazoles Mice Mice, Nude

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Cited by (4)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:25.021412+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK